TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

BIOCON LTD

NeurologyOncology
Generics

BIOCON LTD is a generic drug manufacturer focused on Neurology, Oncology. Key products include PEMETREXED.

2019
Since
2
Drugs
-
Trials
32
Approved (2yr)

Key Drugs

PEMETREXED
pemetrexed disodium
Oncology
Dihydrofolate Reductase 2 indications · 2020

Recent Activity

FINGOLIMOD HYDROCHLORIDE 2026-02-24
Labeling
FINGOLIMOD HYDROCHLORIDE 2026-02-18
Labeling
FINGOLIMOD HYDROCHLORIDE 2026-02-18
Labeling
FINGOLIMOD HYDROCHLORIDE 2026-01-16
Labeling
FINGOLIMOD HYDROCHLORIDE 2025-04-28
Labeling
FINGOLIMOD HYDROCHLORIDE 2025-04-28
Labeling
FINGOLIMOD HYDROCHLORIDE 2025-02-19
Labeling
FINGOLIMOD HYDROCHLORIDE 2025-01-22
Labeling
FINGOLIMOD HYDROCHLORIDE 2025-01-22
Labeling
FINGOLIMOD HYDROCHLORIDE 2025-01-22
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Neurology 50%
1 drugs
Oncology 50%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

AbbVie big-pharma
Oncology, Neurology
GSK big-pharma
Oncology, Neurology
Eli Lilly big-pharma
Oncology, Neurology
Roche big-pharma
Oncology, Neurology
Bristol-Myers Squibb big-pharma
Oncology, Neurology